A registered patient, designated caregiver, or the registered patient's parent or legal guardian, if the parent or legal guardian will be acting as a caregiver, must present a government-issued photo identification at the distribution site. Distribution site staff must verify the identity of the person and the patient's enrollment in the registry.
The pharmacist employed by a manufacturer to distribute medical cannabis must consult with the registered patient, designated caregiver, or the registered patient's parent or legal guardian, if the parent or legal guardian will be acting as a caregiver, before distributing medical cannabis to the recipient. The consultation must include:
a review of patient information in the medical cannabis registry;
an assessment of the perceived effectiveness of medical cannabis in treating the condition or symptoms of the condition;
a review of current medications the patient is taking, including the formulation and current dosage of medical cannabis; and
a review of any changes in the patient's medical condition.
After completing the consultation, the pharmacist will determine a recommended daily dosage and calculate an amount equal to a 30-day supply at maximum recommended dosage.
A registered qualifying patient, registered designated caregiver, or a patient's registered parent or registered legal guardian may purchase medical cannabis in quantities less than or equal to the patient's 30-day supply determined under subpart 3 from any Minnesota distribution site at any time. The total quantity of medical cannabis purchased for a patient in a 23-day period must not exceed the patient's 30-day supply.
39 SR 1760; 40 SR 1599
June 20, 2016
Official Publication of the State of Minnesota
Revisor of Statutes